{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:58:59Z","timestamp":1771977539560,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Grants-in-Aid from KAKENHI","award":["22K09843, 25K12899"],"award-info":[{"award-number":["22K09843, 25K12899"]}]},{"name":"Grants-in-Aid from KAKENHI","award":["23K15944"],"award-info":[{"award-number":["23K15944"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11607-2","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:14:44Z","timestamp":1771928084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Axonal protection by nicotinamide riboside with the SIRT1-AMPK pathway in TNF-induced optic nerve damage"],"prefix":"10.1007","volume":"53","author":[{"given":"Yasushi","family":"Kitaoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibuki","family":"Arizono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Otsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Sase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"11607_CR1","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.3390\/jcm14176145","volume":"14","author":"A Martucci","year":"2025","unstructured":"Martucci A, Cesareo M, Pinazo-Dur\u00e1n MD, Aiello F, Pocobelli G, Mancino R, Nucci C (2025) Next-Gen Neuroprotection in Glaucoma: Synergistic Molecules for Targeted Therapy. J Clin Med 14:6145","journal-title":"J Clin Med"},{"key":"11607_CR2","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1167\/iovs.19-27099","volume":"60","author":"J Kouassi Nzoughet","year":"2019","unstructured":"Kouassi Nzoughet J, de la Chao JM, Guehlouz K, Leruez S, Coulbault L, Allouche S, Bocca C, Muller J, Amati-Bonneau P, Gohier P, Bonneau D, Simard G, Milea D, Lenaers G, Procaccio V, Reynier P (2019) Nicotinamide Deficiency in Primary Open-Angle Glaucoma. Invest Ophthalmol Vis Sci 60:2509\u20132514","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"11607_CR3","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/s41591-024-03068-6","volume":"30","author":"B Petriti","year":"2024","unstructured":"Petriti B, Rabiolo A, Chau KY, Williams PA, Montesano G, Lascaratos G, Garway-Heath DF (2024) Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss. Nat Med 30:2362\u20132370","journal-title":"Nat Med"},{"key":"11607_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams PA, Harder JM, Foxworth NE, Cochran KE, Philip VM, Porciatti V, Smithies O, John SW (2017) Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science 355:756\u2013760","journal-title":"Science"},{"key":"11607_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/NEN.0b013e3181afecfa","volume":"68","author":"Y Kitaoka","year":"2009","unstructured":"Kitaoka Y, Hayashi Y, Kumai T, Takeda H, Munemasa Y, Fujino H, Kitaoka Y, Ueno S, Sadun AA, Lam TT (2009) Axonal and cell body protection by nicotinamide adenine dinucleotide in tumor necrosis factor-induced optic neuropathy. J Neuropathol Exp Neurol 68:915\u2013927","journal-title":"J Neuropathol Exp Neurol"},{"key":"11607_CR6","doi-asserted-by":"publisher","first-page":"12948","DOI":"10.1038\/ncomms12948","volume":"7","author":"SA Trammell","year":"2016","unstructured":"Trammell SA, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, Li Z, Abel ED, Migaud ME, Brenner C (2016) Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun 7:12948","journal-title":"Nat Commun"},{"key":"11607_CR7","first-page":"2284","volume":"92","author":"RPR Nanga","year":"2024","unstructured":"Nanga RPR, Wiers CE, Elliott MA, Wilson NE, Liu F, Cao Q, Swago S, Jacobs PS, Armbruster R, Reddy D, Baur JA, Witschey WR, Detre JA, Reddy R (2024) Acute nicotinamide riboside supplementation increases human cerebral NAD(+) levels in vivo. Magn Reson Med 92:2284\u20132293","journal-title":"Magn Reson Med"},{"key":"11607_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cell.2007.03.024","volume":"129","author":"P Belenky","year":"2007","unstructured":"Belenky P, Racette FG, Bogan KL, McClure JM, Smith JS, Brenner C (2007) Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1\/Pnp1\/Meu1 pathways to NAD+. Cell 129:473\u2013484","journal-title":"Cell"},{"key":"11607_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1753-4887.2006.tb00192.x","volume":"64","author":"G Wolf","year":"2006","unstructured":"Wolf G (2006) Calorie restriction increases life span: a molecular mechanism. Nutr Rev 64:89\u201392","journal-title":"Nutr Rev"},{"key":"11607_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","volume":"24","author":"S Imai","year":"2014","unstructured":"Imai S, Guarente L (2014) NAD\u2009+\u2009and Sirtuins in Aging and Disease. Trends Cell Biol 24:464\u2013471","journal-title":"Trends Cell Biol"},{"key":"11607_CR11","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1007\/s12035-020-02063-5","volume":"57","author":"Y Kitaoka","year":"2020","unstructured":"Kitaoka Y, Sase K, Tsukahara C, Fujita N, Arizono I, Takagi H (2020) Axonal Protection by Nicotinamide Riboside via SIRT1-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration. Mol Neurobiol 57:4952\u20134960","journal-title":"Mol Neurobiol"},{"key":"11607_CR12","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.3390\/cimb45090449","volume":"45","author":"I Arizono","year":"2023","unstructured":"Arizono I, Fujita N, Tsukahara C, Sase K, Sekine R, Jujo T, Otsubo M, Tokuda N, Kitaoka Y (2023) Axonal Protection by Oral Nicotinamide Riboside Treatment with Upregulated AMPK Phosphorylation in a Rat Glaucomatous Degeneration Model. Curr Issues Mol Biol 45:7097\u20137109","journal-title":"Curr Issues Mol Biol"},{"key":"11607_CR13","doi-asserted-by":"publisher","first-page":"9733","DOI":"10.1007\/s11033-020-06008-y","volume":"47","author":"K Sase","year":"2020","unstructured":"Sase K, Tsukahara C, Fujita N, Arizono I, Takagi H, Kitaoka Y (2020) Akebia Saponin D prevents axonal loss against TNF-induced optic nerve damage with autophagy modulation. Mol Biol Rep 47:9733\u20139738","journal-title":"Mol Biol Rep"},{"key":"11607_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.63.1.4","volume":"63","author":"Y Kitaoka","year":"2022","unstructured":"Kitaoka Y, Sase K, Tsukahara C, Fujita N, Arizono I, Kogo J, Tokuda N, Takagi H (2022) Axonal Protection by Netarsudil, a ROCK Inhibitor, Is Linked to an AMPK-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration. Invest Ophthalmol Vis Sci 63:4","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"11607_CR15","doi-asserted-by":"publisher","first-page":"107846","DOI":"10.1016\/j.intimp.2021.107846","volume":"98","author":"J Guo","year":"2021","unstructured":"Guo J, Li B, Wang J, Guo R, Tian Y, Song S, Guo L (2021) Protective effect and mechanism of nicotinamide adenine dinucleotide against optic neuritis in mice with experimental autoimmune encephalomyelitis. Int Immunopharmacol 98:107846","journal-title":"Int Immunopharmacol"},{"key":"11607_CR16","doi-asserted-by":"publisher","first-page":"110126","DOI":"10.1016\/j.exer.2024.110126","volume":"248","author":"N Zhang","year":"2024","unstructured":"Zhang N, Ji D, Hu Y, Zhang P, Deng X, Zhu M, Zeng W, Ke M (2024) The role of nicotinamide riboside in the preservation of retinal ganglion cells using an in vitro glutamate-induced excitotoxicity model. Exp Eye Res 248:110126","journal-title":"Exp Eye Res"},{"key":"11607_CR17","doi-asserted-by":"crossref","unstructured":"Bogan KL, Brenner C (2008) Nicotinic acid, nicotinamide, and nicotinamide riboside a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr 28:115\u2013130","DOI":"10.1146\/annurev.nutr.28.061807.155443"},{"key":"11607_CR18","first-page":"101476","volume":"34","author":"Y Imi","year":"2023","unstructured":"Imi Y, Amano R, Kasahara N, Obana Y, Hosooka T (2023) Nicotinamide mononucleotide induces lipolysis by regulating ATGL expression via the SIRT1-AMPK axis in adipocytes. Biochem Biophys Rep 34:101476","journal-title":"Biochem Biophys Rep"},{"key":"11607_CR19","doi-asserted-by":"publisher","first-page":"1545585","DOI":"10.3389\/fphar.2025.1545585","volume":"16","author":"Y Lin","year":"2025","unstructured":"Lin Y, Wang Y, Yang X, Ding Z, Hu M, Huang X, Zhang Q, Yu Y (2025) NMN reverses D-galactose-induced neurodegeneration and enhances the intestinal barrier of mice by activating the Sirt1 pathway. Front Pharmacol 16:1545585","journal-title":"Front Pharmacol"},{"key":"11607_CR20","doi-asserted-by":"publisher","first-page":"671563","DOI":"10.3389\/fphar.2021.671563","volume":"12","author":"ZH Wang","year":"2021","unstructured":"Wang ZH, Bao XG, Hu JJ, Shen SB, Xu GH, Wu YL (2021) Nicotinamide Riboside Enhances Endothelial Precursor Cell Function to Promote Refractory Wound Healing Through Mediating the Sirt1\/AMPK Pathway. Front Pharmacol 12:671563","journal-title":"Front Pharmacol"},{"key":"11607_CR21","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1002\/glia.24442","volume":"71","author":"K Sato","year":"2023","unstructured":"Sato K, Ohno-Oishi M, Yoshida M, Sato T, Aizawa T, Sasaki Y, Maekawa S, Ishikawa M, Omodaka K, Kawano C, Ohue-Kitano R, Kimura I, Nakazawa T (2023) The GPR84 molecule is a mediator of a subpopulation of retinal microglia that promote TNF\/IL-1\u03b1 expression via the rho-ROCK pathway after optic nerve injury. Glia 71:2609\u20132622","journal-title":"Glia"},{"key":"11607_CR22","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1167\/iovs.05-0299","volume":"47","author":"Y Kitaoka","year":"2006","unstructured":"Kitaoka Y, Kitaoka Y, Kwong JM, Ross-Cisneros FN, Wang J, Tsai RK, Sadun AA, Lam TT (2006) TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. Invest Ophthalmol Vis Sci 47:1448\u20131457","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"11607_CR23","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1007\/s00125-021-05431-5","volume":"64","author":"SS Hammer","year":"2021","unstructured":"Hammer SS, Vieira CP, McFarland D, Sandler M, Levitsky Y, Dorweiler TF, Lydic TA, Asare-Bediako B, Adu-Agyeiwaah Y, Sielski MS, Dupont M, Longhini AL, Li Calzi S, Chakraborty D, Seigel GM, Proshlyakov DA, Grant MB, Busik JV (2021) Fasting and fasting-mimicking treatment activate SIRT1\/LXRalpha and alleviate diabetes-induced systemic and microvascular dysfunction. Diabetologia 64:1674\u20131689","journal-title":"Diabetologia"},{"key":"11607_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s10384-020-00731-6","volume":"64","author":"Y Kitaoka","year":"2020","unstructured":"Kitaoka Y, Sase K, Tsukahara C, Fujita N, Tokuda N, Kogo J, Takagi H (2020) Axonal protection by a small molecule SIRT1 activator, SRT2104, with alteration of autophagy in TNF-induced optic nerve degeneration. Jpn J Ophthalmol 64:298\u2013303","journal-title":"Jpn J Ophthalmol"},{"key":"11607_CR25","doi-asserted-by":"publisher","first-page":"13585","DOI":"10.1038\/s41598-025-97456-8","volume":"15","author":"B Chaqour","year":"2025","unstructured":"Chaqour B, Rossman JB, Meng M, Dine KE, Ross AG, Shindler KS (2025) SIRT1-based therapy targets a gene program involved in mitochondrial turnover in a model of retinal neurodegeneration. Sci Rep 15:13585","journal-title":"Sci Rep"},{"key":"11607_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ogla.2025.01.002","volume":"8","author":"AG Shukla","year":"2025","unstructured":"Shukla AG, Cioffi GA, John SWM, Wang Q, Liebmann JM, American Glaucoma Society and American Academy of Ophthalmology (2025) American Glaucoma Society-American Academy of Ophthalmology Position Statement on Nicotinamide Use for Glaucoma Neuroprotection. Ophthalmol Glaucoma 8:112\u2013116","journal-title":"Ophthalmol Glaucoma"},{"key":"11607_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s11357-023-00999-9","volume":"46","author":"ME Orr","year":"2024","unstructured":"Orr ME, Kotkowski E, Ramirez P, Bair-Kelps D, Liu Q, Brenner C, Schmidt MS, Fox PT, Larbi A, Tan C, Wong G, Gelfond J, Frost B, Espinoza S, Musi N, Powers B (2024) A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. Geroscience 46:665\u2013682","journal-title":"Geroscience"},{"key":"11607_CR28","doi-asserted-by":"publisher","first-page":"bjo","DOI":"10.1136\/bjo-2025-328096","volume":"2025 Oct 30","author":"A Ha","year":"2025","unstructured":"Ha A, Kim YK, Lee CK, Williams PA, Morgan JE, Shin YI, Kim E, Kim M, Rho S (2025) Effects of nicotinamide supplementation in normal-tension glaucoma: a crossover placebo-controlled randomised clinical trial. Br J Ophthalmol 2025 Oct 30:bjo\u20132025. https:\/\/doi.org\/10.1136\/bjo-2025-328096. Online ahead of print","journal-title":"Br J Ophthalmol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11607-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11607-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11607-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:04:56Z","timestamp":1771974296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11607-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11607"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11607-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was approved by the Ethics Committee of the Institute of Experimental Animals of St. Marianna University Graduate School of Medicine (approval no: 2408002, 2508009).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"418"}}